文献速递妇科

现代妇科肿瘤组织库的工具包

A toolkit for a modern gynecologic oncology tissue bank.
PubMed 文献 · Gynecol Oncol · 2024-07-05

本文描述某妇科肿瘤组织库自1992年成立后于2022年8月使用内部资金进行现代化改造的基础设施与流程,包括雇佣3名全职员工、实施普遍筛查、更新知情同意流程和标准化沟通。2022年8月至2023年10月共入组227例患者(83%白人、15%黑人、1%亚裔),收集4249份标本,并从15例卵巢癌患者生成贴壁细胞系、从46例卵巢癌患者收集用于类器官生成的细胞悬液。

要点

  • 组织库现代化包括雇佣3名全职员工、普遍筛查、更新知情同意和标准化沟通。
  • 2022年8月至2023年10月入组227例患者,收集4249份标本。
  • 从15例卵巢癌患者生成贴壁细胞系,从46例卵巢癌患者收集类器官生成用细胞悬液。

核心结论

  • 该组织库入组了大量多样化患者、收集了多种标本类型并广泛合作,所描述的流程可为其他机构建立类似资源提供指导。

研究设计与样本

  • 描述某妇科肿瘤组织库的基础设施与流程,该组织库成立于1992年,于2022年8月使用内部资金进行现代化改造。

主要发现

  • 2022年8月至2023年10月共入组227例患者,其中83%白人、15%黑人、1%亚裔,收集4249份标本。
  • 从15例卵巢癌患者生成贴壁细胞系,从46例卵巢癌患者收集用于类器官生成的细胞悬液。
  • 建立了充值中心以维持组织库自我维持,样本已与学术和商业合作者共享。

关键数值与推荐

  • 每个组织部位取一份福尔马林固定石蜡包埋(FFPE)样本由委员会认证的病理学家分析以进行质量控制。
  • 所有样本在OpenSpecimen采集方案中标记和追踪,并在安全数据库中进行临床注释。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Tissue banking procedures have evolved to keep pace with precision medicine, technology, emerging understanding of racial disparities, and regulatory requirements. However, there is little published guidance regarding strategies to create and maintain a successful biorepository. Our objective is to describe the infrastructure and protocols used by our Gynecologic Oncology Tissue Bank. METHODS: Our Tissue Bank was founded in 1992. In August 2022, internal funding was used to modernize the Tissue Bank. We hired three full-time employees, implemented universal screening of patients treated by gynecologic oncology faculty, updated consenting protocols, and standardized communication with providers. Tumor tissue, blood derivatives, ascites, and pleural fluid were collected from eligible, consenting patients and processed. Patient-derived cell lines and organoids were generated. For quality control purposes, one formalin-fixed, paraffin-embedded (FFPE) sample per tissue site was analyzed by a board-certified pathologist. All samples were labeled and tracked in an OpenSpecimen collection protocol and clinically annotated in a secure database. RESULTS: From August 2022 to October 2023, 227 patients (83% white, 15% Black, 1% Asian) were enrolled and 4249 specimens were collected. Adherent cell lines were generated from 15 patients with ovarian cancer and cell suspensions for organoid generation were collected from 46 patients with ovarian cancer. A recharge center was established to self-sustain the Tissue Bank. Samples have been shared with academic and commercial collaborators. CONCLUSIONS: Our Tissue Bank has enrolled a large number of diverse patients, collected numerous specimen types, and collaborated widely. The procedures described here provide guidance for other institutions establishing similar resources.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Graham O, Rodriguez J, Abbott R, et al. A toolkit for a modern gynecologic oncology tissue bank. Gynecol Oncol. 2024. PMID: 38971004. doi:10.1016/j.ygyno.2024.07.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。